Wenzhou Kangning Hospital Co. Ltd (4WK) - Net Assets
Based on the latest financial reports, Wenzhou Kangning Hospital Co. Ltd (4WK) has net assets worth €1.36 Billion EUR (≈ $1.59 Billion USD) as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€3.05 Billion ≈ $3.56 Billion USD) and total liabilities (€1.69 Billion ≈ $1.97 Billion USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check how resilient are Wenzhou Kangning Hospital Co. Ltd's assets to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €1.36 Billion |
| % of Total Assets | 44.65% |
| Annual Growth Rate | 3.23% |
| 5-Year Change | 2.2% |
| 10-Year Change | N/A |
| Growth Volatility | 4.43 |
Wenzhou Kangning Hospital Co. Ltd - Net Assets Trend (2016–2024)
This chart illustrates how Wenzhou Kangning Hospital Co. Ltd's net assets have evolved over time, based on quarterly financial data. Also explore Wenzhou Kangning Hospital Co. Ltd assets under control for the complete picture of this company's asset base.
Annual Net Assets for Wenzhou Kangning Hospital Co. Ltd (2016–2024)
The table below shows the annual net assets of Wenzhou Kangning Hospital Co. Ltd from 2016 to 2024. For live valuation and market cap data, see 4WK company net worth.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | €1.34 Billion ≈ $1.57 Billion |
-4.61% |
| 2023-12-31 | €1.41 Billion ≈ $1.65 Billion |
+6.21% |
| 2022-12-31 | €1.33 Billion ≈ $1.55 Billion |
+4.31% |
| 2021-12-31 | €1.27 Billion ≈ $1.49 Billion |
-3.30% |
| 2020-12-31 | €1.31 Billion ≈ $1.54 Billion |
+4.19% |
| 2019-12-31 | €1.26 Billion ≈ $1.47 Billion |
+4.67% |
| 2018-12-31 | €1.21 Billion ≈ $1.41 Billion |
+8.53% |
| 2017-12-31 | €1.11 Billion ≈ $1.30 Billion |
+6.64% |
| 2016-12-31 | €1.04 Billion ≈ $1.22 Billion |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Wenzhou Kangning Hospital Co. Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 146.4% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | €344.29 Million | 28.15% |
| Other Components | €878.73 Million | 71.85% |
| Total Equity | €1.22 Billion | 100.00% |
Wenzhou Kangning Hospital Co. Ltd Competitors by Market Cap
The table below lists competitors of Wenzhou Kangning Hospital Co. Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Fabrity Holding S.A.
WAR:FAB
|
$19.28 Million |
|
Saedong Co.Ltd
KQ:053060
|
$19.28 Million |
|
Excelsior Capital Ltd
AU:ECL
|
$19.28 Million |
|
Innovative Rfk SpA
PA:MLIRF
|
$19.29 Million |
|
GR.SOU.COP. LS-01
F:E9E
|
$19.26 Million |
|
Rocketdna Ltd
AU:RKT
|
$19.25 Million |
|
EDGE TOTAL INTELLIGENCE
F:Q5I
|
$19.23 Million |
|
LQR House Inc
NASDAQ:YHC
|
$19.23 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Wenzhou Kangning Hospital Co. Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 1,265,064,696 to 1,223,012,795, a change of -42,051,902 (-3.3%).
- Net income of 65,610,189 contributed positively to equity growth.
- Dividend payments of 71,731,090 reduced retained earnings.
- Other factors decreased equity by 35,931,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €65.61 Million | +5.36% |
| Dividends Paid | €71.73 Million | -5.87% |
| Other Changes | €-35.93 Million | -2.94% |
| Total Change | €- | -3.32% |
Book Value vs Market Value Analysis
This analysis compares Wenzhou Kangning Hospital Co. Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.06x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | €14.40 | €0.94 | x |
| 2018-12-31 | €14.85 | €0.94 | x |
| 2019-12-31 | €15.42 | €0.94 | x |
| 2020-12-31 | €16.24 | €0.94 | x |
| 2021-12-31 | €16.07 | €0.94 | x |
| 2022-12-31 | €16.11 | €0.94 | x |
| 2023-12-31 | €16.96 | €0.94 | x |
| 2024-12-31 | €16.83 | €0.94 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Wenzhou Kangning Hospital Co. Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 5.36%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 3.97%
- • Asset Turnover: 0.55x
- • Equity Multiplier: 2.46x
- Recent ROE (5.36%) is above the historical average (4.80%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2016 | 6.83% | 16.57% | 0.26x | 1.59x | €-32.01 Million |
| 2017 | 4.67% | 7.36% | 0.39x | 1.61x | €-56.11 Million |
| 2018 | 7.19% | 10.80% | 0.41x | 1.64x | €-31.50 Million |
| 2019 | 4.92% | 6.66% | 0.41x | 1.82x | €-59.16 Million |
| 2020 | 5.78% | 6.79% | 0.46x | 1.86x | €-51.18 Million |
| 2021 | 3.67% | 3.40% | 0.55x | 1.98x | €-75.86 Million |
| 2022 | -2.02% | -1.63% | 0.56x | 2.20x | €-144.38 Million |
| 2023 | 6.79% | 5.38% | 0.52x | 2.41x | €-40.56 Million |
| 2024 | 5.36% | 3.97% | 0.55x | 2.46x | €-56.69 Million |
Industry Comparison
This section compares Wenzhou Kangning Hospital Co. Ltd's net assets metrics with peer companies in the Medical Care Facilities industry.
Industry Context
- Industry: Medical Care Facilities
- Average net assets among peers: $6,365,845,985
- Average return on equity (ROE) among peers: -82.74%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Wenzhou Kangning Hospital Co. Ltd (4WK) | €1.36 Billion | 6.83% | 1.24x | $19.28 Million |
| China Resources Medical Holdings Company Limited (1PH) | $7.01 Billion | 3.67% | 0.95x | $428.88 Million |
| AEST.MED.INT.HLD.SP.ADR/3 (3FMA) | $-125.88 Million | 0.00% | 0.00x | $3.30 Million |
| JINXIN FERT.GRP HD-00001 (3NX) | $10.35 Billion | 2.73% | 0.45x | $720.78 Million |
| REVITALIST L.A.W. LTD (4DO) | $1.87 Million | -771.24% | 4.54x | $744.60K |
| Bumrungrad Hospital Public Company Limited (BZ7A) | $24.10 Billion | 29.08% | 0.21x | $50.38K |
| Eifelhöhen-Klinik AG (EIF) | $9.88 Million | -19.11% | 6.64x | $8.99 Million |
| Fresenius Medical Care AG & Co. KGaA (FME) | $2.01 Billion | -12.28% | 1.84x | $12.02 Billion |
| Fresenius Medical Care AG & Co. KGaA (FMEA) | $10.83 Billion | 11.82% | 1.22x | $11.58 Billion |
| Fresenius SE & Co. KGaA (FRE) | $3.10 Billion | 10.64% | 3.84x | $26.87 Billion |
About Wenzhou Kangning Hospital Co. Ltd
Wenzhou Kangning Hospital Co., Ltd., together with its subsidiaries, operates a network of healthcare facilities in the People's Republic of China. The company provides psychiatric specialty care and elderly rehabilitation services. It is also involved in property leasing and management; provision of hospital management, medical services, technology, and nursing care services; drug retail and pha… Read more